Atara Biotherapeutics (ATRA) EBITDA (2013 - 2026)
Atara Biotherapeutics (ATRA) posted EBITDA of -$3.4 million for Q1 2026, down 31.45% on a QoQ basis from -$2.6 million in Q4 2025, and down 108.68% year-over-year from $38.8 million in Q1 2025.
Atara Biotherapeutics (ATRA) EBITDA (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' EBITDA history runs 14 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- Quarterly EBITDA fell 108.68% year-over-year to -$3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 52.88% YoY) and the FY2025 annual result came in at $35.9 million, up 142.98% from the prior year.
- EBITDA was -$3.4 million for Q1 2026 at Atara Biotherapeutics, down from -$2.6 million in the prior quarter.
- Across five years, EBITDA topped out at $38.8 million in Q1 2025 and bottomed at -$88.2 million in Q1 2022.
- A 5-year average of -$35.7 million and a median of -$31.2 million in 2024 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2023 — EBITDA slumped 122.25% — and 2025, when it surged 224.18%.
- Atara Biotherapeutics' EBITDA stood at -$75.5 million in 2022, then increased by 20.62% to -$60.0 million in 2023, then surged by 79.65% to -$12.2 million in 2024, then soared by 79.0% to -$2.6 million in 2025, then plunged by 31.45% to -$3.4 million in 2026.
- Business Quant data shows ATRA's EBITDA at -$3.4 million in Q1 2026, -$2.6 million in Q4 2025, and -$3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -445.22 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -3.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.37 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -3.57 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 38.80 Mn |
| Dec 31, 2024 | -12.20 Mn |
| Sep 30, 2024 | -21.76 Mn |
| Jun 30, 2024 | -18.23 Mn |
| Mar 31, 2024 | -31.25 Mn |
| Dec 31, 2023 | -59.96 Mn |
| Sep 30, 2023 | -69.61 Mn |
| Jun 30, 2023 | -71.41 Mn |
| Mar 31, 2023 | -75.02 Mn |
| Dec 31, 2022 | -75.54 Mn |
| Sep 30, 2022 | -84.62 Mn |
| Jun 30, 2022 | -32.13 Mn |
| Mar 31, 2022 | -88.22 Mn |
| Dec 31, 2021 | -93.40 Mn |
| Sep 30, 2021 | -84.81 Mn |
| Jun 30, 2021 | -84.00 Mn |